Global Psychostimulants Supply, Demand and Key Producers, 2023-2029
The global Psychostimulants market size is expected to reach $ 1755.2 million by 2029, rising at a market growth of 5.7% CAGR during the forecast period (2023-2029).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Psychostimulants are a class of drugs that stimulate the central nervous system, increasing alertness, excitement, and energy while reducing fatigue and drowsiness. These medications are often used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, depression, or in special situations such as work environments where alertness is required.
This report studies the global Psychostimulants production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Psychostimulants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Psychostimulants that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Psychostimulants total production and demand, 2018-2029, (K Units)
Global Psychostimulants total production value, 2018-2029, (USD Million)
Global Psychostimulants production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Psychostimulants consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Psychostimulants domestic production, consumption, key domestic manufacturers and share
Global Psychostimulants production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Psychostimulants production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Psychostimulants production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Psychostimulants market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer and Teva Pharmaceutical Industries, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Psychostimulants market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Psychostimulants Market, By Region:
1. How big is the global Psychostimulants market?
2. What is the demand of the global Psychostimulants market?
3. What is the year over year growth of the global Psychostimulants market?
4. What is the production and production value of the global Psychostimulants market?
5. Who are the key producers in the global Psychostimulants market?
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Psychostimulants are a class of drugs that stimulate the central nervous system, increasing alertness, excitement, and energy while reducing fatigue and drowsiness. These medications are often used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, depression, or in special situations such as work environments where alertness is required.
This report studies the global Psychostimulants production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Psychostimulants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Psychostimulants that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Psychostimulants total production and demand, 2018-2029, (K Units)
Global Psychostimulants total production value, 2018-2029, (USD Million)
Global Psychostimulants production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Psychostimulants consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Psychostimulants domestic production, consumption, key domestic manufacturers and share
Global Psychostimulants production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Psychostimulants production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Psychostimulants production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Psychostimulants market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer and Teva Pharmaceutical Industries, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Psychostimulants market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Psychostimulants Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Non-prescription Drugs
- Prescription
- Hospital
- Clinic
- Other
- Alkermes
- Allergan
- Bristol-Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline
- Lundbeck
- Merck
- Pfizer
- Teva Pharmaceutical Industries
- Takeda Pharmaceutical
- Johnson and Johnson
- Sanofi
- Astrazeneca
- Bayer HealthCare Pharmaceuticals
- Boehringer Ingelheim GmbH
1. How big is the global Psychostimulants market?
2. What is the demand of the global Psychostimulants market?
3. What is the year over year growth of the global Psychostimulants market?
4. What is the production and production value of the global Psychostimulants market?
5. Who are the key producers in the global Psychostimulants market?
1 SUPPLY SUMMARY
1.1 Psychostimulants Introduction
1.2 World Psychostimulants Supply & Forecast
1.2.1 World Psychostimulants Production Value (2018 & 2022 & 2029)
1.2.2 World Psychostimulants Production (2018-2029)
1.2.3 World Psychostimulants Pricing Trends (2018-2029)
1.3 World Psychostimulants Production by Region (Based on Production Site)
1.3.1 World Psychostimulants Production Value by Region (2018-2029)
1.3.2 World Psychostimulants Production by Region (2018-2029)
1.3.3 World Psychostimulants Average Price by Region (2018-2029)
1.3.4 North America Psychostimulants Production (2018-2029)
1.3.5 Europe Psychostimulants Production (2018-2029)
1.3.6 China Psychostimulants Production (2018-2029)
1.3.7 Japan Psychostimulants Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Psychostimulants Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Psychostimulants Major Market Trends
2 DEMAND SUMMARY
2.1 World Psychostimulants Demand (2018-2029)
2.2 World Psychostimulants Consumption by Region
2.2.1 World Psychostimulants Consumption by Region (2018-2023)
2.2.2 World Psychostimulants Consumption Forecast by Region (2024-2029)
2.3 United States Psychostimulants Consumption (2018-2029)
2.4 China Psychostimulants Consumption (2018-2029)
2.5 Europe Psychostimulants Consumption (2018-2029)
2.6 Japan Psychostimulants Consumption (2018-2029)
2.7 South Korea Psychostimulants Consumption (2018-2029)
2.8 ASEAN Psychostimulants Consumption (2018-2029)
2.9 India Psychostimulants Consumption (2018-2029)
3 WORLD PSYCHOSTIMULANTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Psychostimulants Production Value by Manufacturer (2018-2023)
3.2 World Psychostimulants Production by Manufacturer (2018-2023)
3.3 World Psychostimulants Average Price by Manufacturer (2018-2023)
3.4 Psychostimulants Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Psychostimulants Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Psychostimulants in 2022
3.5.3 Global Concentration Ratios (CR8) for Psychostimulants in 2022
3.6 Psychostimulants Market: Overall Company Footprint Analysis
3.6.1 Psychostimulants Market: Region Footprint
3.6.2 Psychostimulants Market: Company Product Type Footprint
3.6.3 Psychostimulants Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Psychostimulants Production Value Comparison
4.1.1 United States VS China: Psychostimulants Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Psychostimulants Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Psychostimulants Production Comparison
4.2.1 United States VS China: Psychostimulants Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Psychostimulants Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Psychostimulants Consumption Comparison
4.3.1 United States VS China: Psychostimulants Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Psychostimulants Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Psychostimulants Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Psychostimulants Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Psychostimulants Production Value (2018-2023)
4.4.3 United States Based Manufacturers Psychostimulants Production (2018-2023)
4.5 China Based Psychostimulants Manufacturers and Market Share
4.5.1 China Based Psychostimulants Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Psychostimulants Production Value (2018-2023)
4.5.3 China Based Manufacturers Psychostimulants Production (2018-2023)
4.6 Rest of World Based Psychostimulants Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Psychostimulants Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Psychostimulants Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Psychostimulants Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Psychostimulants Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-prescription Drugs
5.2.2 Prescription
5.3 Market Segment by Type
5.3.1 World Psychostimulants Production by Type (2018-2029)
5.3.2 World Psychostimulants Production Value by Type (2018-2029)
5.3.3 World Psychostimulants Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Psychostimulants Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Psychostimulants Production by Application (2018-2029)
6.3.2 World Psychostimulants Production Value by Application (2018-2029)
6.3.3 World Psychostimulants Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Alkermes
7.1.1 Alkermes Details
7.1.2 Alkermes Major Business
7.1.3 Alkermes Psychostimulants Product and Services
7.1.4 Alkermes Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Alkermes Recent Developments/Updates
7.1.6 Alkermes Competitive Strengths & Weaknesses
7.2 Allergan
7.2.1 Allergan Details
7.2.2 Allergan Major Business
7.2.3 Allergan Psychostimulants Product and Services
7.2.4 Allergan Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Allergan Recent Developments/Updates
7.2.6 Allergan Competitive Strengths & Weaknesses
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Details
7.3.2 Bristol-Myers Squibb Major Business
7.3.3 Bristol-Myers Squibb Psychostimulants Product and Services
7.3.4 Bristol-Myers Squibb Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bristol-Myers Squibb Recent Developments/Updates
7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Details
7.4.2 Eli Lilly and Company Major Business
7.4.3 Eli Lilly and Company Psychostimulants Product and Services
7.4.4 Eli Lilly and Company Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Eli Lilly and Company Recent Developments/Updates
7.4.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Details
7.5.2 GlaxoSmithKline Major Business
7.5.3 GlaxoSmithKline Psychostimulants Product and Services
7.5.4 GlaxoSmithKline Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GlaxoSmithKline Recent Developments/Updates
7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.6 Lundbeck
7.6.1 Lundbeck Details
7.6.2 Lundbeck Major Business
7.6.3 Lundbeck Psychostimulants Product and Services
7.6.4 Lundbeck Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lundbeck Recent Developments/Updates
7.6.6 Lundbeck Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Psychostimulants Product and Services
7.7.4 Merck Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Psychostimulants Product and Services
7.8.4 Pfizer Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Details
7.9.2 Teva Pharmaceutical Industries Major Business
7.9.3 Teva Pharmaceutical Industries Psychostimulants Product and Services
7.9.4 Teva Pharmaceutical Industries Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
7.9.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Details
7.10.2 Takeda Pharmaceutical Major Business
7.10.3 Takeda Pharmaceutical Psychostimulants Product and Services
7.10.4 Takeda Pharmaceutical Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Pharmaceutical Recent Developments/Updates
7.10.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Details
7.11.2 Johnson and Johnson Major Business
7.11.3 Johnson and Johnson Psychostimulants Product and Services
7.11.4 Johnson and Johnson Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Johnson and Johnson Recent Developments/Updates
7.11.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.12 Sanofi
7.12.1 Sanofi Details
7.12.2 Sanofi Major Business
7.12.3 Sanofi Psychostimulants Product and Services
7.12.4 Sanofi Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sanofi Recent Developments/Updates
7.12.6 Sanofi Competitive Strengths & Weaknesses
7.13 Astrazeneca
7.13.1 Astrazeneca Details
7.13.2 Astrazeneca Major Business
7.13.3 Astrazeneca Psychostimulants Product and Services
7.13.4 Astrazeneca Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Astrazeneca Recent Developments/Updates
7.13.6 Astrazeneca Competitive Strengths & Weaknesses
7.14 Bayer HealthCare Pharmaceuticals
7.14.1 Bayer HealthCare Pharmaceuticals Details
7.14.2 Bayer HealthCare Pharmaceuticals Major Business
7.14.3 Bayer HealthCare Pharmaceuticals Psychostimulants Product and Services
7.14.4 Bayer HealthCare Pharmaceuticals Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bayer HealthCare Pharmaceuticals Recent Developments/Updates
7.14.6 Bayer HealthCare Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Boehringer Ingelheim GmbH
7.15.1 Boehringer Ingelheim GmbH Details
7.15.2 Boehringer Ingelheim GmbH Major Business
7.15.3 Boehringer Ingelheim GmbH Psychostimulants Product and Services
7.15.4 Boehringer Ingelheim GmbH Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Boehringer Ingelheim GmbH Recent Developments/Updates
7.15.6 Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Psychostimulants Industry Chain
8.2 Psychostimulants Upstream Analysis
8.2.1 Psychostimulants Core Raw Materials
8.2.2 Main Manufacturers of Psychostimulants Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Psychostimulants Production Mode
8.6 Psychostimulants Procurement Model
8.7 Psychostimulants Industry Sales Model and Sales Channels
8.7.1 Psychostimulants Sales Model
8.7.2 Psychostimulants Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Psychostimulants Introduction
1.2 World Psychostimulants Supply & Forecast
1.2.1 World Psychostimulants Production Value (2018 & 2022 & 2029)
1.2.2 World Psychostimulants Production (2018-2029)
1.2.3 World Psychostimulants Pricing Trends (2018-2029)
1.3 World Psychostimulants Production by Region (Based on Production Site)
1.3.1 World Psychostimulants Production Value by Region (2018-2029)
1.3.2 World Psychostimulants Production by Region (2018-2029)
1.3.3 World Psychostimulants Average Price by Region (2018-2029)
1.3.4 North America Psychostimulants Production (2018-2029)
1.3.5 Europe Psychostimulants Production (2018-2029)
1.3.6 China Psychostimulants Production (2018-2029)
1.3.7 Japan Psychostimulants Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Psychostimulants Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Psychostimulants Major Market Trends
2 DEMAND SUMMARY
2.1 World Psychostimulants Demand (2018-2029)
2.2 World Psychostimulants Consumption by Region
2.2.1 World Psychostimulants Consumption by Region (2018-2023)
2.2.2 World Psychostimulants Consumption Forecast by Region (2024-2029)
2.3 United States Psychostimulants Consumption (2018-2029)
2.4 China Psychostimulants Consumption (2018-2029)
2.5 Europe Psychostimulants Consumption (2018-2029)
2.6 Japan Psychostimulants Consumption (2018-2029)
2.7 South Korea Psychostimulants Consumption (2018-2029)
2.8 ASEAN Psychostimulants Consumption (2018-2029)
2.9 India Psychostimulants Consumption (2018-2029)
3 WORLD PSYCHOSTIMULANTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Psychostimulants Production Value by Manufacturer (2018-2023)
3.2 World Psychostimulants Production by Manufacturer (2018-2023)
3.3 World Psychostimulants Average Price by Manufacturer (2018-2023)
3.4 Psychostimulants Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Psychostimulants Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Psychostimulants in 2022
3.5.3 Global Concentration Ratios (CR8) for Psychostimulants in 2022
3.6 Psychostimulants Market: Overall Company Footprint Analysis
3.6.1 Psychostimulants Market: Region Footprint
3.6.2 Psychostimulants Market: Company Product Type Footprint
3.6.3 Psychostimulants Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Psychostimulants Production Value Comparison
4.1.1 United States VS China: Psychostimulants Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Psychostimulants Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Psychostimulants Production Comparison
4.2.1 United States VS China: Psychostimulants Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Psychostimulants Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Psychostimulants Consumption Comparison
4.3.1 United States VS China: Psychostimulants Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Psychostimulants Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Psychostimulants Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Psychostimulants Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Psychostimulants Production Value (2018-2023)
4.4.3 United States Based Manufacturers Psychostimulants Production (2018-2023)
4.5 China Based Psychostimulants Manufacturers and Market Share
4.5.1 China Based Psychostimulants Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Psychostimulants Production Value (2018-2023)
4.5.3 China Based Manufacturers Psychostimulants Production (2018-2023)
4.6 Rest of World Based Psychostimulants Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Psychostimulants Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Psychostimulants Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Psychostimulants Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Psychostimulants Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-prescription Drugs
5.2.2 Prescription
5.3 Market Segment by Type
5.3.1 World Psychostimulants Production by Type (2018-2029)
5.3.2 World Psychostimulants Production Value by Type (2018-2029)
5.3.3 World Psychostimulants Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Psychostimulants Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Psychostimulants Production by Application (2018-2029)
6.3.2 World Psychostimulants Production Value by Application (2018-2029)
6.3.3 World Psychostimulants Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Alkermes
7.1.1 Alkermes Details
7.1.2 Alkermes Major Business
7.1.3 Alkermes Psychostimulants Product and Services
7.1.4 Alkermes Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Alkermes Recent Developments/Updates
7.1.6 Alkermes Competitive Strengths & Weaknesses
7.2 Allergan
7.2.1 Allergan Details
7.2.2 Allergan Major Business
7.2.3 Allergan Psychostimulants Product and Services
7.2.4 Allergan Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Allergan Recent Developments/Updates
7.2.6 Allergan Competitive Strengths & Weaknesses
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Details
7.3.2 Bristol-Myers Squibb Major Business
7.3.3 Bristol-Myers Squibb Psychostimulants Product and Services
7.3.4 Bristol-Myers Squibb Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bristol-Myers Squibb Recent Developments/Updates
7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Details
7.4.2 Eli Lilly and Company Major Business
7.4.3 Eli Lilly and Company Psychostimulants Product and Services
7.4.4 Eli Lilly and Company Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Eli Lilly and Company Recent Developments/Updates
7.4.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Details
7.5.2 GlaxoSmithKline Major Business
7.5.3 GlaxoSmithKline Psychostimulants Product and Services
7.5.4 GlaxoSmithKline Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GlaxoSmithKline Recent Developments/Updates
7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.6 Lundbeck
7.6.1 Lundbeck Details
7.6.2 Lundbeck Major Business
7.6.3 Lundbeck Psychostimulants Product and Services
7.6.4 Lundbeck Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lundbeck Recent Developments/Updates
7.6.6 Lundbeck Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Psychostimulants Product and Services
7.7.4 Merck Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Psychostimulants Product and Services
7.8.4 Pfizer Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Details
7.9.2 Teva Pharmaceutical Industries Major Business
7.9.3 Teva Pharmaceutical Industries Psychostimulants Product and Services
7.9.4 Teva Pharmaceutical Industries Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
7.9.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Details
7.10.2 Takeda Pharmaceutical Major Business
7.10.3 Takeda Pharmaceutical Psychostimulants Product and Services
7.10.4 Takeda Pharmaceutical Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Pharmaceutical Recent Developments/Updates
7.10.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Details
7.11.2 Johnson and Johnson Major Business
7.11.3 Johnson and Johnson Psychostimulants Product and Services
7.11.4 Johnson and Johnson Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Johnson and Johnson Recent Developments/Updates
7.11.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.12 Sanofi
7.12.1 Sanofi Details
7.12.2 Sanofi Major Business
7.12.3 Sanofi Psychostimulants Product and Services
7.12.4 Sanofi Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sanofi Recent Developments/Updates
7.12.6 Sanofi Competitive Strengths & Weaknesses
7.13 Astrazeneca
7.13.1 Astrazeneca Details
7.13.2 Astrazeneca Major Business
7.13.3 Astrazeneca Psychostimulants Product and Services
7.13.4 Astrazeneca Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Astrazeneca Recent Developments/Updates
7.13.6 Astrazeneca Competitive Strengths & Weaknesses
7.14 Bayer HealthCare Pharmaceuticals
7.14.1 Bayer HealthCare Pharmaceuticals Details
7.14.2 Bayer HealthCare Pharmaceuticals Major Business
7.14.3 Bayer HealthCare Pharmaceuticals Psychostimulants Product and Services
7.14.4 Bayer HealthCare Pharmaceuticals Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bayer HealthCare Pharmaceuticals Recent Developments/Updates
7.14.6 Bayer HealthCare Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Boehringer Ingelheim GmbH
7.15.1 Boehringer Ingelheim GmbH Details
7.15.2 Boehringer Ingelheim GmbH Major Business
7.15.3 Boehringer Ingelheim GmbH Psychostimulants Product and Services
7.15.4 Boehringer Ingelheim GmbH Psychostimulants Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Boehringer Ingelheim GmbH Recent Developments/Updates
7.15.6 Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Psychostimulants Industry Chain
8.2 Psychostimulants Upstream Analysis
8.2.1 Psychostimulants Core Raw Materials
8.2.2 Main Manufacturers of Psychostimulants Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Psychostimulants Production Mode
8.6 Psychostimulants Procurement Model
8.7 Psychostimulants Industry Sales Model and Sales Channels
8.7.1 Psychostimulants Sales Model
8.7.2 Psychostimulants Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Psychostimulants Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Psychostimulants Production Value by Region (2018-2023) & (USD Million)
Table 3. World Psychostimulants Production Value by Region (2024-2029) & (USD Million)
Table 4. World Psychostimulants Production Value Market Share by Region (2018-2023)
Table 5. World Psychostimulants Production Value Market Share by Region (2024-2029)
Table 6. World Psychostimulants Production by Region (2018-2023) & (K Units)
Table 7. World Psychostimulants Production by Region (2024-2029) & (K Units)
Table 8. World Psychostimulants Production Market Share by Region (2018-2023)
Table 9. World Psychostimulants Production Market Share by Region (2024-2029)
Table 10. World Psychostimulants Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Psychostimulants Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Psychostimulants Major Market Trends
Table 13. World Psychostimulants Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Psychostimulants Consumption by Region (2018-2023) & (K Units)
Table 15. World Psychostimulants Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Psychostimulants Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Psychostimulants Producers in 2022
Table 18. World Psychostimulants Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Psychostimulants Producers in 2022
Table 20. World Psychostimulants Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Psychostimulants Company Evaluation Quadrant
Table 22. World Psychostimulants Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Psychostimulants Production Site of Key Manufacturer
Table 24. Psychostimulants Market: Company Product Type Footprint
Table 25. Psychostimulants Market: Company Product Application Footprint
Table 26. Psychostimulants Competitive Factors
Table 27. Psychostimulants New Entrant and Capacity Expansion Plans
Table 28. Psychostimulants Mergers & Acquisitions Activity
Table 29. United States VS China Psychostimulants Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Psychostimulants Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Psychostimulants Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Psychostimulants Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Psychostimulants Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Psychostimulants Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Psychostimulants Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Psychostimulants Production Market Share (2018-2023)
Table 37. China Based Psychostimulants Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Psychostimulants Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Psychostimulants Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Psychostimulants Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Psychostimulants Production Market Share (2018-2023)
Table 42. Rest of World Based Psychostimulants Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Psychostimulants Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Psychostimulants Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Psychostimulants Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Psychostimulants Production Market Share (2018-2023)
Table 47. World Psychostimulants Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Psychostimulants Production by Type (2018-2023) & (K Units)
Table 49. World Psychostimulants Production by Type (2024-2029) & (K Units)
Table 50. World Psychostimulants Production Value by Type (2018-2023) & (USD Million)
Table 51. World Psychostimulants Production Value by Type (2024-2029) & (USD Million)
Table 52. World Psychostimulants Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Psychostimulants Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Psychostimulants Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Psychostimulants Production by Application (2018-2023) & (K Units)
Table 56. World Psychostimulants Production by Application (2024-2029) & (K Units)
Table 57. World Psychostimulants Production Value by Application (2018-2023) & (USD Million)
Table 58. World Psychostimulants Production Value by Application (2024-2029) & (USD Million)
Table 59. World Psychostimulants Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Psychostimulants Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Alkermes Basic Information, Manufacturing Base and Competitors
Table 62. Alkermes Major Business
Table 63. Alkermes Psychostimulants Product and Services
Table 64. Alkermes Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Alkermes Recent Developments/Updates
Table 66. Alkermes Competitive Strengths & Weaknesses
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Psychostimulants Product and Services
Table 70. Allergan Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Allergan Recent Developments/Updates
Table 72. Allergan Competitive Strengths & Weaknesses
Table 73. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 74. Bristol-Myers Squibb Major Business
Table 75. Bristol-Myers Squibb Psychostimulants Product and Services
Table 76. Bristol-Myers Squibb Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bristol-Myers Squibb Recent Developments/Updates
Table 78. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 79. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 80. Eli Lilly and Company Major Business
Table 81. Eli Lilly and Company Psychostimulants Product and Services
Table 82. Eli Lilly and Company Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Eli Lilly and Company Recent Developments/Updates
Table 84. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 86. GlaxoSmithKline Major Business
Table 87. GlaxoSmithKline Psychostimulants Product and Services
Table 88. GlaxoSmithKline Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 91. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 92. Lundbeck Major Business
Table 93. Lundbeck Psychostimulants Product and Services
Table 94. Lundbeck Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lundbeck Recent Developments/Updates
Table 96. Lundbeck Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Psychostimulants Product and Services
Table 100. Merck Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Psychostimulants Product and Services
Table 106. Pfizer Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 110. Teva Pharmaceutical Industries Major Business
Table 111. Teva Pharmaceutical Industries Psychostimulants Product and Services
Table 112. Teva Pharmaceutical Industries Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Teva Pharmaceutical Industries Recent Developments/Updates
Table 114. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 115. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Takeda Pharmaceutical Major Business
Table 117. Takeda Pharmaceutical Psychostimulants Product and Services
Table 118. Takeda Pharmaceutical Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Takeda Pharmaceutical Recent Developments/Updates
Table 120. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 122. Johnson and Johnson Major Business
Table 123. Johnson and Johnson Psychostimulants Product and Services
Table 124. Johnson and Johnson Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Johnson and Johnson Recent Developments/Updates
Table 126. Johnson and Johnson Competitive Strengths & Weaknesses
Table 127. Sanofi Basic Information, Manufacturing Base and Competitors
Table 128. Sanofi Major Business
Table 129. Sanofi Psychostimulants Product and Services
Table 130. Sanofi Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sanofi Recent Developments/Updates
Table 132. Sanofi Competitive Strengths & Weaknesses
Table 133. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 134. Astrazeneca Major Business
Table 135. Astrazeneca Psychostimulants Product and Services
Table 136. Astrazeneca Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Astrazeneca Recent Developments/Updates
Table 138. Astrazeneca Competitive Strengths & Weaknesses
Table 139. Bayer HealthCare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 140. Bayer HealthCare Pharmaceuticals Major Business
Table 141. Bayer HealthCare Pharmaceuticals Psychostimulants Product and Services
Table 142. Bayer HealthCare Pharmaceuticals Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bayer HealthCare Pharmaceuticals Recent Developments/Updates
Table 144. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 145. Boehringer Ingelheim GmbH Major Business
Table 146. Boehringer Ingelheim GmbH Psychostimulants Product and Services
Table 147. Boehringer Ingelheim GmbH Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Psychostimulants Upstream (Raw Materials)
Table 149. Psychostimulants Typical Customers
Table 150. Psychostimulants Typical Distributors
LIST OF FIGURE
Figure 1. Psychostimulants Picture
Figure 2. World Psychostimulants Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Psychostimulants Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Psychostimulants Production (2018-2029) & (K Units)
Figure 5. World Psychostimulants Average Price (2018-2029) & (US$/Unit)
Figure 6. World Psychostimulants Production Value Market Share by Region (2018-2029)
Figure 7. World Psychostimulants Production Market Share by Region (2018-2029)
Figure 8. North America Psychostimulants Production (2018-2029) & (K Units)
Figure 9. Europe Psychostimulants Production (2018-2029) & (K Units)
Figure 10. China Psychostimulants Production (2018-2029) & (K Units)
Figure 11. Japan Psychostimulants Production (2018-2029) & (K Units)
Figure 12. Psychostimulants Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Psychostimulants Consumption (2018-2029) & (K Units)
Figure 15. World Psychostimulants Consumption Market Share by Region (2018-2029)
Figure 16. United States Psychostimulants Consumption (2018-2029) & (K Units)
Figure 17. China Psychostimulants Consumption (2018-2029) & (K Units)
Figure 18. Europe Psychostimulants Consumption (2018-2029) & (K Units)
Figure 19. Japan Psychostimulants Consumption (2018-2029) & (K Units)
Figure 20. South Korea Psychostimulants Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Psychostimulants Consumption (2018-2029) & (K Units)
Figure 22. India Psychostimulants Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Psychostimulants by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Psychostimulants Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Psychostimulants Markets in 2022
Figure 26. United States VS China: Psychostimulants Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Psychostimulants Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Psychostimulants Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Psychostimulants Production Market Share 2022
Figure 30. China Based Manufacturers Psychostimulants Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Psychostimulants Production Market Share 2022
Figure 32. World Psychostimulants Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Psychostimulants Production Value Market Share by Type in 2022
Figure 34. Non-prescription Drugs
Figure 35. Prescription
Figure 36. World Psychostimulants Production Market Share by Type (2018-2029)
Figure 37. World Psychostimulants Production Value Market Share by Type (2018-2029)
Figure 38. World Psychostimulants Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Psychostimulants Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Psychostimulants Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Psychostimulants Production Market Share by Application (2018-2029)
Figure 45. World Psychostimulants Production Value Market Share by Application (2018-2029)
Figure 46. World Psychostimulants Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Psychostimulants Industry Chain
Figure 48. Psychostimulants Procurement Model
Figure 49. Psychostimulants Sales Model
Figure 50. Psychostimulants Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Psychostimulants Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Psychostimulants Production Value by Region (2018-2023) & (USD Million)
Table 3. World Psychostimulants Production Value by Region (2024-2029) & (USD Million)
Table 4. World Psychostimulants Production Value Market Share by Region (2018-2023)
Table 5. World Psychostimulants Production Value Market Share by Region (2024-2029)
Table 6. World Psychostimulants Production by Region (2018-2023) & (K Units)
Table 7. World Psychostimulants Production by Region (2024-2029) & (K Units)
Table 8. World Psychostimulants Production Market Share by Region (2018-2023)
Table 9. World Psychostimulants Production Market Share by Region (2024-2029)
Table 10. World Psychostimulants Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Psychostimulants Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Psychostimulants Major Market Trends
Table 13. World Psychostimulants Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Psychostimulants Consumption by Region (2018-2023) & (K Units)
Table 15. World Psychostimulants Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Psychostimulants Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Psychostimulants Producers in 2022
Table 18. World Psychostimulants Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Psychostimulants Producers in 2022
Table 20. World Psychostimulants Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Psychostimulants Company Evaluation Quadrant
Table 22. World Psychostimulants Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Psychostimulants Production Site of Key Manufacturer
Table 24. Psychostimulants Market: Company Product Type Footprint
Table 25. Psychostimulants Market: Company Product Application Footprint
Table 26. Psychostimulants Competitive Factors
Table 27. Psychostimulants New Entrant and Capacity Expansion Plans
Table 28. Psychostimulants Mergers & Acquisitions Activity
Table 29. United States VS China Psychostimulants Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Psychostimulants Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Psychostimulants Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Psychostimulants Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Psychostimulants Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Psychostimulants Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Psychostimulants Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Psychostimulants Production Market Share (2018-2023)
Table 37. China Based Psychostimulants Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Psychostimulants Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Psychostimulants Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Psychostimulants Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Psychostimulants Production Market Share (2018-2023)
Table 42. Rest of World Based Psychostimulants Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Psychostimulants Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Psychostimulants Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Psychostimulants Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Psychostimulants Production Market Share (2018-2023)
Table 47. World Psychostimulants Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Psychostimulants Production by Type (2018-2023) & (K Units)
Table 49. World Psychostimulants Production by Type (2024-2029) & (K Units)
Table 50. World Psychostimulants Production Value by Type (2018-2023) & (USD Million)
Table 51. World Psychostimulants Production Value by Type (2024-2029) & (USD Million)
Table 52. World Psychostimulants Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Psychostimulants Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Psychostimulants Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Psychostimulants Production by Application (2018-2023) & (K Units)
Table 56. World Psychostimulants Production by Application (2024-2029) & (K Units)
Table 57. World Psychostimulants Production Value by Application (2018-2023) & (USD Million)
Table 58. World Psychostimulants Production Value by Application (2024-2029) & (USD Million)
Table 59. World Psychostimulants Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Psychostimulants Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Alkermes Basic Information, Manufacturing Base and Competitors
Table 62. Alkermes Major Business
Table 63. Alkermes Psychostimulants Product and Services
Table 64. Alkermes Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Alkermes Recent Developments/Updates
Table 66. Alkermes Competitive Strengths & Weaknesses
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Psychostimulants Product and Services
Table 70. Allergan Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Allergan Recent Developments/Updates
Table 72. Allergan Competitive Strengths & Weaknesses
Table 73. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 74. Bristol-Myers Squibb Major Business
Table 75. Bristol-Myers Squibb Psychostimulants Product and Services
Table 76. Bristol-Myers Squibb Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bristol-Myers Squibb Recent Developments/Updates
Table 78. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 79. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 80. Eli Lilly and Company Major Business
Table 81. Eli Lilly and Company Psychostimulants Product and Services
Table 82. Eli Lilly and Company Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Eli Lilly and Company Recent Developments/Updates
Table 84. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 86. GlaxoSmithKline Major Business
Table 87. GlaxoSmithKline Psychostimulants Product and Services
Table 88. GlaxoSmithKline Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 91. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 92. Lundbeck Major Business
Table 93. Lundbeck Psychostimulants Product and Services
Table 94. Lundbeck Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lundbeck Recent Developments/Updates
Table 96. Lundbeck Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Psychostimulants Product and Services
Table 100. Merck Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Psychostimulants Product and Services
Table 106. Pfizer Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 110. Teva Pharmaceutical Industries Major Business
Table 111. Teva Pharmaceutical Industries Psychostimulants Product and Services
Table 112. Teva Pharmaceutical Industries Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Teva Pharmaceutical Industries Recent Developments/Updates
Table 114. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 115. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Takeda Pharmaceutical Major Business
Table 117. Takeda Pharmaceutical Psychostimulants Product and Services
Table 118. Takeda Pharmaceutical Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Takeda Pharmaceutical Recent Developments/Updates
Table 120. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 122. Johnson and Johnson Major Business
Table 123. Johnson and Johnson Psychostimulants Product and Services
Table 124. Johnson and Johnson Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Johnson and Johnson Recent Developments/Updates
Table 126. Johnson and Johnson Competitive Strengths & Weaknesses
Table 127. Sanofi Basic Information, Manufacturing Base and Competitors
Table 128. Sanofi Major Business
Table 129. Sanofi Psychostimulants Product and Services
Table 130. Sanofi Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sanofi Recent Developments/Updates
Table 132. Sanofi Competitive Strengths & Weaknesses
Table 133. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 134. Astrazeneca Major Business
Table 135. Astrazeneca Psychostimulants Product and Services
Table 136. Astrazeneca Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Astrazeneca Recent Developments/Updates
Table 138. Astrazeneca Competitive Strengths & Weaknesses
Table 139. Bayer HealthCare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 140. Bayer HealthCare Pharmaceuticals Major Business
Table 141. Bayer HealthCare Pharmaceuticals Psychostimulants Product and Services
Table 142. Bayer HealthCare Pharmaceuticals Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bayer HealthCare Pharmaceuticals Recent Developments/Updates
Table 144. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 145. Boehringer Ingelheim GmbH Major Business
Table 146. Boehringer Ingelheim GmbH Psychostimulants Product and Services
Table 147. Boehringer Ingelheim GmbH Psychostimulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Psychostimulants Upstream (Raw Materials)
Table 149. Psychostimulants Typical Customers
Table 150. Psychostimulants Typical Distributors
LIST OF FIGURE
Figure 1. Psychostimulants Picture
Figure 2. World Psychostimulants Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Psychostimulants Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Psychostimulants Production (2018-2029) & (K Units)
Figure 5. World Psychostimulants Average Price (2018-2029) & (US$/Unit)
Figure 6. World Psychostimulants Production Value Market Share by Region (2018-2029)
Figure 7. World Psychostimulants Production Market Share by Region (2018-2029)
Figure 8. North America Psychostimulants Production (2018-2029) & (K Units)
Figure 9. Europe Psychostimulants Production (2018-2029) & (K Units)
Figure 10. China Psychostimulants Production (2018-2029) & (K Units)
Figure 11. Japan Psychostimulants Production (2018-2029) & (K Units)
Figure 12. Psychostimulants Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Psychostimulants Consumption (2018-2029) & (K Units)
Figure 15. World Psychostimulants Consumption Market Share by Region (2018-2029)
Figure 16. United States Psychostimulants Consumption (2018-2029) & (K Units)
Figure 17. China Psychostimulants Consumption (2018-2029) & (K Units)
Figure 18. Europe Psychostimulants Consumption (2018-2029) & (K Units)
Figure 19. Japan Psychostimulants Consumption (2018-2029) & (K Units)
Figure 20. South Korea Psychostimulants Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Psychostimulants Consumption (2018-2029) & (K Units)
Figure 22. India Psychostimulants Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Psychostimulants by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Psychostimulants Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Psychostimulants Markets in 2022
Figure 26. United States VS China: Psychostimulants Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Psychostimulants Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Psychostimulants Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Psychostimulants Production Market Share 2022
Figure 30. China Based Manufacturers Psychostimulants Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Psychostimulants Production Market Share 2022
Figure 32. World Psychostimulants Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Psychostimulants Production Value Market Share by Type in 2022
Figure 34. Non-prescription Drugs
Figure 35. Prescription
Figure 36. World Psychostimulants Production Market Share by Type (2018-2029)
Figure 37. World Psychostimulants Production Value Market Share by Type (2018-2029)
Figure 38. World Psychostimulants Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Psychostimulants Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Psychostimulants Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Psychostimulants Production Market Share by Application (2018-2029)
Figure 45. World Psychostimulants Production Value Market Share by Application (2018-2029)
Figure 46. World Psychostimulants Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Psychostimulants Industry Chain
Figure 48. Psychostimulants Procurement Model
Figure 49. Psychostimulants Sales Model
Figure 50. Psychostimulants Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
